Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.70EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.63EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.63ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BM.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used